Answer
Nilotinib can cause grade 3–4 thrombocytopenia (low platelets), neutropenia (low neutrophils) and anaemia, more frequently in imatinib-resistant or intolerant CML, particularly accelerated-phase CML; this myelosuppression is generally reversible.
Sources for this answer
- Tasigna 50mg, 150mg and 200 mg hard capsulesNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 39Document updated
Sources checked